Emergence of Multidrug Resistance in Leukemia Cells During Chemotherapy: Mechanisms and Prevention

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Hematotherapy & Stem Cell Research

• Publication date

  2002-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/152581602753658439PMID 11983096
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells

  2012cited by this paper
• Signal transduction pathways and transcriptional mechanisms as targets for prevention of emergence of multidrug resistance in human cancer cells.

  2001cited by this paper
• Signal transduction by MAP kinases in T lymphocytes

  2001cited by this paper
• Activation of phospholipase C induces the expression of the multidrug resistance (MDR1) gene through the Raf-MAPK pathway.

  2001cited by this paper
• Involvement of nuclear factor-kappa B (NF-kappaB) activation in mitogen-induced lymphocyte proliferation: inhibitory effects of lymphoproliferation by salicylates acting as NF-kappaB inhibitors.

  2001cited by this paper
• Down-regulation of Intrinsic P-glycoprotein Expression in Multicellular Prostate Tumor Spheroids by Reactive Oxygen Species*

  2001cited by this paper
• Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children

  2001cited by this paper
• ATRA(ouble) in the treatment of acute promyelocytic leukemia.

  2001cited by this paper
• Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents.

  2001cited by this paper
• Differential Effects of the MDR1 (Multidrug Resistance) Gene-Activating Agents on Protein Kinase C: Evidence for Redundancy of Mechanisms of Acquired MDR in Leukemia Cells

  2000cited by this paper
• Identification and characterization of the MDR1 promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line.

  2000cited by this paper
• NF-κB Inhibits Apoptosis in Murine Mammary Epithelia*

  2000cited by this paper
• Novel mechanisms of drug resistance in leukemia

  2000cited by this paper
• P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway.

  2000cited by this paper
• Regulation of MDR1 gene expression: emerging concepts.

  2000cited by this paper
• NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events.

  2000cited by this paper
• Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells.

  2000cited by this paper
• NF-kappaB inhibits apoptosis in murine mammary epithelia.

  2000cited by this paper
• Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation.

  2000cited by this paper
• Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all‐trans retinoic acid

  2000cited by this paper
• NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells.

  2000cited by this paper
• Regulation of RANTES Chemokine Gene Expression Requires Cooperativity Between NF-κB and IFN-Regulatory Factor Transcription Factors1

  2000cited by this paper
• Chemotherapeutic DNA-damaging drugs activate interferon regulatory factor-7 by the mitogen-activated protein kinase kinase-4-cJun NH2-terminal kinase pathway.

  2000cited by this paper
• Up-regulation of Multidrug Resistance P-glycoprotein via Nuclear Factor-κB Activation Protects Kidney Proximal Tubule Cells from Cadmium- and Reactive Oxygen Species-induced Apoptosis*

  2000cited by this paper
• Overexpression of P-glycoprotein is associated with a decreased mitochondrial transmembrane potential in doxorubicin-selected K562 human leukemia cells.

  2000cited by this paper
• Phorbol ester induced MDR1 expression in K562 cells occurs independently of mitogen-activated protein kinase signaling pathways

  1999cited by this paper
• Recent progress in P-glycoprotein research.

  1999cited by this paper
• Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells.

  1999cited by this paper
• The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.

  1999cited by this paper
• Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.

  1999cited by this paper
• NF-κB as a primary regulator of the stress response

  1999cited by this paper
• Multidrug resistance-associated protein subfamily transporters and drug resistance.

  1999cited by this paper
• How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.

  1999cited by this paper
• How NF-κB is activated: the role of the IκB kinase (IKK) complex

  1999cited by this paper
• Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy

  1999cited by this paper
• P‐glycoprotein, lung resistance‐related protein and multidrug resistance associated protein in de novo acute non‐lymphocytic leukaemias: biological and clinical implications

  1999cited by this paper
• NF-kappaB as a primary regulator of the stress response.

  1999cited by this paper
• P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death.

  1999cited by this paper
• Studies of some mechanisms of drug resistance in chronic myeloid leukemia (CML).

  1999cited by this paper
• The Contribution of P‐glycoprotein to Pharmacokinetic Drug‐Drug Interactions

  1999cited by this paper
• The ubiquitin system.

  1998cited by this paper
• Prognostic value of P-glycoprotein and leukocyte differentiation antigens in chronic myeloid leukemia.

  1998cited by this paper
• The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis.

  1998cited by this paper
• Glucosylceramide: a marker for multiple-drug resistant cancers.

  1998cited by this paper
• Promotion of antigen-specific antibody production in murine B cells by a moderate increase in histone acetylation.

  1998cited by this paper
• 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase.

  1998cited by this paper
• Influence of exogenous RAR alpha gene on MDR1 expression and P-glycoprotein function in human and rodent cell lines.

  1998influential reference
• Transcriptional Regulation of the MDR1 Gene by Histone Acetyltransferase and Deacetylase Is Mediated by NF-Y

  1998influential reference
• IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival.

  1998cited by this paper
• Transcriptional regulation of MDR genes

  1998cited by this paper
• Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P‐glycoprotein over‐expression

  1998cited by this paper
• Multidrug resistance in aggressive lymphoproliferative disorders of T and natural-killer origin.

  1998cited by this paper
• Molecular Mechanisms of c-Jun N-terminal Kinase-mediated Apoptosis Induced by Anticarcinogenic Isothiocyanates*

  1998cited by this paper
• Mechanism of action of nonsteroidal anti-inflammatory drugs.

  1998cited by this paper
• Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteins.

  1998cited by this paper
• The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta.

  1998cited by this paper
• Overexpression of lung‐resistance protein and increased P‐glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival

  1998cited by this paper
• IEX-1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell Survival

  1998cited by this paper
• The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β

  1998cited by this paper
• Structure of the multidrug resistance P-glycoprotein.

  1997cited by this paper
• The prognostic value of MDR1 gene expression in primary untreated neuroblastoma.

  1997cited by this paper
• Expression of the MDR1 gene product P‐glycoprotein in childhood neuroblastoma

  1997cited by this paper
• P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity.

  1997cited by this paper
• Multidrug resistance: molecular and clinical aspects.

  1997cited by this paper
• Multidrug resistance — a multiplex phenomenon

  1997cited by this paper
• 60-Hz electric fields inhibit protein kinase C activity and multidrug resistance gene (MDR1) up-regulation.

  1997cited by this paper
• Cytogenetics and P-glycoprotein (PGP) are independent predictors of treatment outcome in acute myeloid leukemia (AML).

  1996cited by this paper
• Inhibition of cytarabine‐induced MDR1 (P‐glycoprotein) gene activation in human tumor cells by fatty acid‐polyethylene glycol‐fatty acid diesters, novel inhibitors of P‐glycoprotein function

  1996cited by this paper
• Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation

  1996cited by this paper
• Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation

  1996cited by this paper
• Adriamycin activates c-jun N-terminal kinase in human leukemia cells: a relevance to apoptosis.

  1996cited by this paper
• Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells*

  1996cited by this paper
• Signal induced degradation of IkBa requires site-specific ubiquitina-tion

  1995cited by this paper
• Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.

  1995cited by this paper
• Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

  1995cited by this paper
• Mechanism of Interaction of Protein Kinase C with Phorbol Esters

  1995cited by this paper
• Prognostic relevance of P-glycoprotein expression in breast cancer.

  1995cited by this paper
• Multidrug resistance gene expression in childhood medulloblastoma: correlation with clinical outcome and DNA ploidy in 29 patients.

  1995cited by this paper
• LIPID MEDIATORS AND PROTEIN KINASE C FOR INTRACELLULAR SIGNALLING

  1995cited by this paper
• Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.

  1995cited by this paper
• Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-kappa B.

  1995cited by this paper
• Protein Kinase C: Structure, Function, and Regulation (*)

  1995cited by this paper
• 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1

  1995cited by this paper
• Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals.

  1995cited by this paper
• Differential utilization of multiple transcription start points accompanies the overexpression of the P-glycoprotein-encoding gene in Chinese hamster lung cells.

  1995cited by this paper
• Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.

  1995cited by this paper
• Lipid mediators and protein kinase C for intracellular signalling.

  1995cited by this paper
• Inhibition of NF-kappa B by sodium salicylate and aspirin.

  1994cited by this paper
• NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene.

  1994cited by this paper
• A proteasome inhibitor prevents activation of NF‐kappa B and stabilizes a newly phosphorylated form of I kappa B‐alpha that is still bound to NF‐kappa B.

  1994cited by this paper
• Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation.

  1993cited by this paper
• Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes.

  1993cited by this paper
• Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.

  1993influential reference
• Identification of 5' and 3' sequences involved in the regulation of transcription of the human mdr1 gene in vivo.

  1993cited by this paper
• Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells

  1992cited by this paper
• Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists.

  1992cited by this paper
• Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists.

  1992influential reference
• Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase.

  1992cited by this paper
• Reversal of Multidrug Resistance by Calcium Channel Blockers and Other Agents

  1991cited by this paper
• Expression of the Multidrug Resistance Gene in Human Cancer

  1991cited by this paper

• Therapy-Induced Tumor Cell Senescence: Mechanisms and Circumvention

  2023cites this paper
• Therapy induced tumor cell senescence: mechanisms and ways to overcome

  2023cites this paper
• Multiple drug resistance in acute myelocytic leukemia/acute lymphocyte leukemia patients and MDR evaluation

  2021cites this paper
• The PI3K/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia

  2017cites this paper
• Leukemia stem cells, direct targeting of CD123 based on the nano-smart polymer PMBN

  2016cites this paper
• STAT3 contributes to NK cell recognition by modulating expression of NKG2D ligands in adriamycin-resistant K562/AO2 cells

  2015cites this paper
• randomized study in adult de novo acute myelogenous leukemia Quinine as a multidrug resistance inhibitor: a phase 3 multicentric

  2013cites this paper
• Immunological Response as a Source to Variability in Drug Metabolism and Transport

  2012cites this paper
• The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma

  2012cites this paper
• Nemorosone blocks proliferation and induces apoptosis in leukemia cells.

  2008cites this paper
• DRUG RESISTANCE IN ACUTE MYELOID LEUKEMIA

  2008cites this paper
• Modulation of P-glycoprotein by zosuquidar trihydrochloride.

  2007cites this paper
• Phase II study of gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): A Children's Oncology Group Report

  2006cites this paper
• Natural selection in neoplastic progression of Barrett's esophagus.

  2005cites this paper
• The synthetic furanonaphthoquinone induces growth arrest, apoptosis and differentiation in a variety of leukaemias and multiple myeloma cells

  2005cites this paper
• Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery.

  2005cites this paper
• Antibody binding capacity for evaluation of MDR‐related proteins in acute promyelocytic leukemia: Onset versus relapse expression

  2004cites this paper
• Induction and postremission therapy: new agents

  2003cites this paper
• Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.

  2003cites this paper
• Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia.

  2003influential citation
• Genomic instability — the engine of tumorigenesis?

  2003cites this paper